# Anda Biotechnology completes Series A+ financing

On 2026-08-01, according to Xiniu Data, Anda Biotechnology completed Series A+ financing for an undisclosed amount. Investors were lead investor Anhui Hongtaihekang Phase One Venture Capital Fund Partnership (Limited Partnership), participating investor Beijing Changping Industry Development Investment Fund (Limited Partnership), participating investor Feixizipeng Venture Capital Partnership (Limited Partnership), participating investor Hefei Guoshengweilaikezhuan Venture Capital Fund Partnership (Limited Partnership). The company is a developer of personalized oncology neoantigen vaccines.



Canonical: https://uniquebase.ai/news/7084216e-891f-4934-b3f1-c64b14c9f403
Stable identifier: 7084216e-891f-4934-b3f1-c64b14c9f403
Snapshot captured: 2026-10-20T18:19:32.670Z
English updated: 2026-10-20T18:31:05.446Z

## Connected profiles

- [Anda Biotechnology](/companies/UB-C6779)
- [Anhui Hongtaihekang Phase One Venture Capital Fund Partnership (Limited Partnership)](/institutions/anhui-hongtaihekang-phase-one-venture-capital-fund-partnership-limited-partnership)
- [Beijing Changping Industry Development Investment Fund (Limited Partnership)](/institutions/beijing-changping-industry-development-investment-fund-limited-partnership)
- [Feixizipeng Venture Capital Partnership (Limited Partnership)](/institutions/feixizipeng-venture-capital-partnership-limited-partnership)
- [Hefei Guoshengweilaikezhuan Venture Capital Fund Partnership (Limited Partnership)](/institutions/hefei-guoshengweilaikezhuan-venture-capital-fund-partnership-limited-partnership)

## Sources

- No source links are available for this profile.